.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
The performance of The Tablet in the Capsules category within the state of California demonstrates a consistent presence in the top 10. Starting the year strong with a 7th place ranking in January 2026, The Tablet maintained its competitive position in the market, albeit with a slight drop to 8th place from February through April. Despite this minor dip, the brand's sales figures reflect resilience, with a noticeable recovery in sales from February's low of $103,140 to $128,826 by April. This suggests a successful strategy in adapting to market fluctuations and maintaining consumer interest.
While The Tablet's ranking stability in California is notable, it is important to consider its absence from the top 30 in other states and categories, which could indicate areas for potential growth or strategic realignment. The brand's focus within California's Capsules category could be a deliberate choice, but expanding its presence across additional states or diversifying into other categories might offer new opportunities for growth. Observing the brand's performance in California could provide insights into its strategies and potential for broader market penetration.
Competitive Landscape
In the competitive landscape of the California capsules market, The Tablet has maintained a consistent rank of 8th place from February to April 2026, despite a slight dip from 7th place in January. This stability is noteworthy given the fluctuations experienced by other brands. For instance, Dr. Norm's consistently held the 7th rank, just above The Tablet, indicating a close competition. Meanwhile, Emerald Bay Extracts maintained a stronger position in the top 5, suggesting a significant gap in market dominance. Papa & Barkley and Proof have shown more volatility, with ranks fluctuating between 9th and 11th positions. The Tablet's sales figures have shown a positive trend from February to April, suggesting a potential for upward movement in rank if this growth continues, especially as it competes closely with Dr. Norm's.
Notable Products
In April 2026, the top-performing product for The Tablet was the Sativa High Dose Tablets 50-Pack (1000mg) in the Capsules category, which rose to the first position with a notable sales figure of 1156 units. Following closely, the Indica High Dose Tablets 50-Pack (1000mg) also climbed in the rankings to secure second place. The Sativa Tablets 20-Pack (1000mg) maintained a strong presence, ranking third, although it slightly dropped from its consistent second-place position in previous months. The Indica Tablets 20-Pack (1000mg), which had been the leader in the first three months of 2026, fell to fourth place in April. This shift in rankings highlights a significant change in consumer preference towards higher dose options within the Capsules category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
